The end of the 12/7/22 R & D Update Discussed HIV

The end of the 12/7/22 R & D Update Discussed HIV PREP and HIV CURE. HIV CURE is when a patient receives one injection of Adeno Associated Virus along with proteins that encode or inserts a copy of its DNA blueprint of the RNA Genome into the DNA of the host cells. Then, that cell is programmed or encoded to express/manufacture leronlimab. Since that programming is duplicated upon cell division, it is with that patient indefinitely and their muscle cells, CD4, and CD8 T Lymphocytes make leronlimab for the rest of their lives.

12/7/22 R & D Update Jonah Sacha, MD